帕瑟诺利德在人类多巴胺转运器中起到可卡因对手的作用
1Department of Biology, West Chester University, West Chester, Pennsylvania, United States.
microPublication biology
|September 15, 2025
概括
帕瑟诺利德是一种天然化合物,影响可卡因与多巴胺转运体的结合. 它似乎还减少了可卡因在安全度下抑制多巴胺吸收的作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 人类多巴胺转运体 (hDAT) 在调节多巴胺基神经传递方面发挥着至关重要的作用.
- 帕瑟诺利德是一种酸乳,在发烧植物中发现,以其抗炎性质而闻名.
- 了解天然化合物如何与神经递质运输体相互作用,对于开发新疗法至关重要.
研究的目的:
- 为了研究帕瑟诺利德对人类多巴胺载体 (hDAT) 的影响.
- 确定帕特诺利德对放射性标记可卡因结合和HEK-293表达hDAT (HEK/DAT细胞) 的细胞中多巴胺吸收的影响.
主要方法:
- 使用HEK/DAT细胞评估帕瑟诺利德与多巴胺载体的相互作用.
- 使用放射性标记的可卡因进行了放射性连接剂结合测定,以测量由帕氏化物所产生的位移.
- 进行了多巴胺吸收测试,以评估帕瑟诺利德对多巴胺运输的影响.
主要成果:
- 帕瑟诺利德显示,放射性标记的可卡因与HEK/DAT细胞结合的位移取决于度.
- 在测试度下,帕瑟诺利德并没有显著抑制放射标记多巴胺的摄取.
- 在亚毒性度下,帕瑟诺利德似乎可以减轻未标记可卡因对多巴胺吸收的抑制作用.
结论:
- 帕瑟诺利德与人类的多巴胺载体相互作用,特别影响连接物结合.
- 这些发现表明,帕瑟诺利德可能调节多巴胺转运器功能,可能为治疗干预提供新的途径.
- 需要进行进一步的研究,以阐明帕瑟诺利德与hDAT相互作用的确切机制及其潜在的临床应用.
相关概念视频
01:25Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:28Drug-Receptor Interaction: Antagonist
4.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
4.9K
01:25Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
815
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
815